무수한 유전학, Inc.
US ˙ NasdaqGS ˙ US62855J1043

SecurityMYGN / Myriad Genetics, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership99,450 shares
Latest Disclosed Value $ 611,618
Alliancebernstein L.p. ownership in MYGN / Myriad Genetics, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 99,450 shares of Myriad Genetics, Inc. (US:MYGN) valued at $447,525 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 99,450 shares of Myriad Genetics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $454,486 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MYRIAD GENETICS COM 62855J104 99,450 0 0.00 612 0.00 0.0002
2026-02-17 2025-12-31 13F MYRIAD GENETICS COM 62855J104 99,450 -1,784 -1.76 612 -16.42 0.0002
2025-11-14 2025-09-30 13F MYRIAD GENETICS COM 62855J104 101,234 1,784 1.79 732 38.45 0.0002
2025-08-14 2025-06-30 13F MYRIAD GENETICS COM 62855J104 99,450 0 0.00 528 -40.14 0.0002
2025-05-15 2025-03-31 13F MYRIAD GENETICS COM 62855J104 99,450 0 0.00 882 -35.29 0.0003
2025-02-12 2024-12-31 13F MYRIAD GENETICS COM 62855J104 99,450 -8,975 -8.28 1,363 -54.09 0.0005
2024-11-14 2024-09-30 13F MYRIAD GENETICS COM 62855J104 108,425 -6,470 -5.63 2,970 5.66 0.0010
2024-08-14 2024-06-30 13F MYRIAD GENETICS COM 62855J104 114,895 1,385 1.22 2,810 16.12 0.0010
2024-05-14 2024-03-31 13F MYRIAD GENETICS COM 62855J104 113,510 5,240 4.84 2,420 16.80 0.0009
2024-02-14 2023-12-31 13F MYRIAD GENETICS COM 62855J104 108,270 0 0.00 2,072 19.35 0.0008
2023-11-14 2023-09-30 13F MYRIAD GENETICS COM 62855J104 108,270 0 0.00 1,737 -30.81 0.0007
2023-08-15 2023-06-30 13F MYRIAD GENETICS COM 62855J104 108,270 0 0.00 2,510 -0.24 0.0010
2023-05-15 2023-03-31 13F MYRIAD GENETICS COM 62855J104 108,270 -11,959 -9.95 2,515 44.21 0.0011
2023-02-15 2022-12-31 13F MYRIAD GENETICS COM 62855J104 120,229 1,830 1.55 1,745 -22.80 0.0008
2022-11-15 2022-09-30 13F MYRIAD GENETICS COM 62855J104 118,399 -3,834 -3.14 2,259 1.71 0.0011
2022-08-15 2022-06-30 13F MYRIAD GENETICS COM 62855J104 122,233 4,162 3.52 2,221 -25.34 0.0010
2022-05-13 2022-03-31 13F MYRIAD GENETICS COM 62855J104 118,071 314 0.27 2,975 -8.46 0.0011
2022-02-14 2021-12-31 13F MYRIAD GENETICS COM 62855J104 117,757 427 0.36 3,250 -14.23 0.0011
2021-11-10 2021-09-30 13F MYRIAD GENETICS COM 62855J104 117,330 -3,870 -3.19 3,789 2.24 0.0015
2021-07-30 2021-06-30 13F MYRIAD GENETICS COM 62855J104 121,200 6,470 5.64 3,706 6.07 0.0015
2021-05-06 2021-03-31 13F MYRIAD GENETICS COM 62855J104 114,730 1,710 1.51 3,494 56.33 0.0015
2021-02-08 2020-12-31 13F MYRIAD GENETICS COM 62855J104 113,020 0 0.00 2,235 51.63 0.0011
2020-11-12 2020-09-30 13F MYRIAD GENETICS COM 62855J104 113,020 170 0.15 1,474 15.16 0.0008
2020-08-13 2020-06-30 13F MYRIAD GENETICS COM 62855J104 112,850 -6,950 -5.80 1,280 -25.32 0.0008
2020-05-14 2020-03-31 13F MYRIAD GENETICS COM 62855J104 119,800 -1,460 -1.20 1,714 -48.09 0.0012
2020-02-18 2019-12-31 13F MYRIAD GENETICS COM 62855J104 121,260 -54,720 -31.09 3,302 -34.46 0.0019
2019-11-14 2019-09-30 13F MYRIAD GENETICS COM 62855J104 175,980 -28,440 -13.91 5,038 -11.29 0.0031
2019-08-14 2019-06-30 13F MYRIAD GENETICS COM 62855J104 204,420 29,800 17.07 5,679 -2.04 0.0035
2019-05-14 2019-03-31 13F MYRIAD GENETICS COM 62855J104 174,620 1,200 0.69 5,797 15.00 0.0038
2019-02-13 2018-12-31 13F MYRIAD GENETICS COM 62855J104 173,420 -6,249 -3.48 5,041 -39.01 0.0037
2018-11-08 2018-09-30 13F MYRIAD GENETICS COM 62855J104 179,669 -11,009 -5.77 8,265 15.98 0.0054
2018-08-13 2018-06-30 13F MYRIAD GENETICS COM 62855J104 190,678 23,458 14.03 7,126 44.22 0.0050
2018-05-14 2018-03-31 13F MYRIAD GENETICS COM 62855J104 167,220 3,290 2.01 4,941 -12.24 0.0036
2018-02-13 2017-12-31 13F MYRIAD GENETICS COM 62855J104 163,930 0 0.00 5,630 -5.08 0.0040
2017-11-13 2017-09-30 13F MYRIAD GENETICS COM 62855J104 163,930 2,420 1.50 5,931 42.13 0.0044
2017-08-10 2017-06-30 13F MYRIAD GENETICS COM 62855J104 161,510 62,000 62.31 4,173 118.37 0.0032
2017-05-11 2017-03-31 13F MYRIAD GENETICS COM 62855J104 99,510 -7,150 -6.70 1,911 7.48 0.0015
2017-02-13 2016-12-31 13F MYRIAD GENETICS COM 62855J104 106,660 -24,754 -18.84 1,778 -34.27 0.0015
2016-11-10 2016-09-30 13F MYRIAD GENETICS COM 62855J104 131,414 -8,510 -6.08 2,705 -36.83 0.0023
2016-08-11 2016-06-30 13F MYRIAD GENETICS COM 62855J104 139,924 6,895 5.18 4,282 -14.00 0.0037
2016-05-13 2016-03-31 13F MYRIAD GENETICS COM 62855J104 133,029 11,339 9.32 4,979 -5.20 0.0042
2016-02-16 2015-12-31 13F/A-1 MYRIAD GENETICS COM 62855J104 121,690 -5,170 -4.08 5,252 10.45 0.0045
2016-02-12 2015-12-31 13F MYRIAD GENETICS COM 62855J104 121,690 4,561
2015-11-13 2015-09-30 13F MYRIAD GENETICS COM 62855J104 126,860 -190 -0.15 4,755 10.12 0.0041
2015-08-14 2015-06-30 13F MYRIAD GENETICS COM 62855J104 127,050 77,866 158.32 4,318 148.02 0.0036
2015-05-13 2015-03-31 13F MYRIAD GENETICS COM 62855J104 49,184 -800 -1.60 1,741 2.29 0.0014
2015-02-13 2014-12-31 13F MYRIAD GENETICS COM 62855J104 49,984 -4,800 -8.76 1,702 -19.45 0.0014
2014-11-13 2014-09-30 13F MYRIAD GENETICS COM 62855J104 54,784 350 0.64 2,113 -0.28 0.0018
2014-08-13 2014-06-30 13F MYRIAD GENETICS COM 62855J104 54,434 -597 -1.08 2,119 12.59 0.0018
2014-05-13 2014-03-31 13F MYRIAD GENETICS COM 62855J104 55,031 3,821 7.46 1,882 75.23 0.0016
2014-02-13 2013-12-31 13F MYRIAD GENETICS COM 62855J104 51,210 -1,730 -3.27 1,074 -13.67 0.0010
2013-11-14 2013-09-30 13F MYRIAD GENETICS COM 62855J104 52,940 595 1.14 1,244 -11.58 0.0012
2013-08-13 2013-06-30 13F MYRIAD GENETICS COM 62855J104 52,345 52,345 1,407 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.